These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26812904)

  • 41. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modelling the interactions between animal venom peptides and membrane proteins.
    Hung A; Kuyucak S; Schroeder CI; Kaas Q
    Neuropharmacology; 2017 Dec; 127():20-31. PubMed ID: 28778835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch.
    Goudet C; Chi CW; Tytgat J
    Toxicon; 2002 Sep; 40(9):1239-58. PubMed ID: 12220709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme.
    Hayashi MA; Camargo AC
    Toxicon; 2005 Jun; 45(8):1163-70. PubMed ID: 15922781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bradykinin-potentiating peptides: beyond captopril.
    Camargo AC; Ianzer D; Guerreiro JR; Serrano SM
    Toxicon; 2012 Mar; 59(4):516-23. PubMed ID: 21835190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The application of phenotypic high-throughput screening techniques to cardiovascular research.
    Etzion Y; Muslin AJ
    Trends Cardiovasc Med; 2009 Aug; 19(6):207-12. PubMed ID: 20211437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?
    Corti R; Burnett JC; Rouleau JL; Ruschitzka F; Lüscher TF
    Circulation; 2001 Oct; 104(15):1856-62. PubMed ID: 11591626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multitarget cardiovascular drugs.
    Trstenjak U; Kikelj D
    Curr Med Chem; 2011; 18(17):2531-42. PubMed ID: 21568894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of kinins in the treatment of cardiovascular diseases.
    Regoli D; Plante GE; Gobeil F
    Pharmacol Ther; 2012 Jul; 135(1):94-111. PubMed ID: 22537664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium Channels and Venom Peptide Pharmacology.
    Israel MR; Tay B; Deuis JR; Vetter I
    Adv Pharmacol; 2017; 79():67-116. PubMed ID: 28528674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Animal Venoms have Potential to Treat Cancer.
    Chatterjee B
    Curr Top Med Chem; 2018; 18(30):2555-2566. PubMed ID: 30574852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Animal toxins and human disease: from single component to venomics, from biochemical characterization to disease mechanisms, from crude venom utilization to rational drug design].
    Lu QM; Lai R; Zhang Y
    Dongwuxue Yanjiu; 2010 Feb; 31(1):2-16. PubMed ID: 20446448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of novel bradykinin-potentiating peptides and C-type natriuretic peptide from Lachesis muta venom.
    Soares MR; Oliveira-Carvalho AL; Wermelinger LS; Zingali RB; Ho PL; Junqueira-de-Azevedo IL; Diniz MR
    Toxicon; 2005 Jul; 46(1):31-8. PubMed ID: 15876444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Cardiovascular and Neurotoxic Effects of the  Venoms of Six Bony and Cartilaginous Fish Species.
    Han H; Baumann K; Casewell NR; Ali SA; Dobson J; Koludarov I; Debono J; Cutmore SC; Rajapakse NW; Jackson TN; Jones R; Hodgson WC; Fry BG; Kuruppu S
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28212333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin converting enzyme of Thalassophryne nattereri venom.
    da Costa Marques ME; de Araújo Tenório H; Dos Santos CW; Dos Santos DM; de Lima ME; Pereira HJ
    Int J Biol Macromol; 2016 Oct; 91():980-6. PubMed ID: 27327905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of snake bradykinin-potentiating peptides (BPPs)-simile sequences in rat brain--Potential BPP-like precursor protein?
    Campeiro JD; Neshich IP; Sant'Anna OA; Lopes R; Ianzer D; Assakura MT; Neshich G; Hayashi MA
    Biochem Pharmacol; 2015 Aug; 96(3):202-15. PubMed ID: 26047849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The modular nature of bradykinin-potentiating peptides isolated from snake venoms.
    Sciani JM; Pimenta DC
    J Venom Anim Toxins Incl Trop Dis; 2017; 23():45. PubMed ID: 29090005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
    Carmona AK; Juliano L
    Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel peptide from the ACEI/BPP-CNP precursor in the venom of Crotalus durissus collilineatus.
    Higuchi S; Murayama N; Saguchi K; Ohi H; Fujita Y; da Silva NJ; de Siqueira RJ; Lahlou S; Aird SD
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Oct; 144(2):107-21. PubMed ID: 16979945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel bradykinin potentiating peptide isolated from Bothrops jararacussu venom using catallytically inactive oligopeptidase EP24.15.
    Rioli V; Prezoto BC; Konno K; Melo RL; Klitzke CF; Ferro ES; Ferreira-Lopes M; Camargo AC; Portaro FC
    FEBS J; 2008 May; 275(10):2442-54. PubMed ID: 18400032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.